Phase II clinical trials (Clinical trial) Archives

Woman lying down suffering from symptoms of long covid after COVID-19

Coronavirus

NIH Opens Phase II Clinical Trials on Four Potential Treatments for Long COVID

Chris Anderson -

August 1, 2023

Scientific illustration of a migrating breast cancer cell - 3d illustration

News & Features

Cancer Immunotherapy Blocked by GDF-15, New Research Shows

Malorye Branca -

July 20, 2023

News & Features

Rare Brain Tumor Shows 91 Percent Response to Existing Cancer Drug Combo

Malorye Branca -

July 13, 2023

News & Features

Immunotherapy Provided Clinical Benefit in Brain Metastases from Diverse Tumors

Christina Jackson -

June 7, 2023

Destruction of leukaemia cell in blood cancer

News & Features

Promising Menin Inhibitor Results from Leukemia Trial Published

Malorye Branca -

March 16, 2023

News & Features

MEI Pharma, Infinity Pharmaceuticals Merge to Advance Oncology Candidates

Chris Anderson -

February 24, 2023

News & Features

Listeria-Based Vaccine Booster Highly Effective Against Recurring Colon Cancer

Chris Anderson -

June 23, 2022

News & Features

Treatment for Inherited High Insulin Levels Shows Promise at Phase II

Helen Albert -

April 14, 2022

News & Features

Combo Therapy Shows Promise for ER-Positive Endometrial Cancer

Chris Anderson -

March 23, 2022

News & Features

Hydroxychloroquine Could Boost Chemotherapy Efficacy in Head and Neck Cancer

Sophia Ktori -

March 15, 2022

123 Page 2 of 3

What’s Driving the Increase in Colorectal Cancer among Younger People?

Insights into Genetic Pathway of Neuroblastoma Uncovered

Patients Aged 80 to 90 Respond to Standard-of-Care AML Treatment

Sylvester Cancer Center Launches Precision-Medicine Focused Brain Tumor Institute

Largest GWAS for Breast Cancer in Women of African Ancestry Reveals…

Phase II clinical trials (Clinical trial)

NIH Opens Phase II Clinical Trials on Four Potential Treatments for Long COVID

Cancer Immunotherapy Blocked by GDF-15, New Research Shows

Rare Brain Tumor Shows 91 Percent Response to Existing Cancer Drug Combo

Immunotherapy Provided Clinical Benefit in Brain Metastases from Diverse Tumors

Promising Menin Inhibitor Results from Leukemia Trial Published

MEI Pharma, Infinity Pharmaceuticals Merge to Advance Oncology Candidates

Listeria-Based Vaccine Booster Highly Effective Against Recurring Colon Cancer

Treatment for Inherited High Insulin Levels Shows Promise at Phase II

Combo Therapy Shows Promise for ER-Positive Endometrial Cancer

Hydroxychloroquine Could Boost Chemotherapy Efficacy in Head and Neck Cancer

Related Content

Sylvester Cancer Center Launches Precision-Medicine Focused Brain Tumor Institute

Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma

Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic Diseases

Zenas Nets $200M to Advance mAb for Autoimmune Diseases